Biotech Stock 685% Draws Big Investment Amid FDA Filings
A biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
This section highlights volatility metrics for the dividend aristocrats ETF, offering key indicators to monitor risk and potential entry points.
22,062 articlesA biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
MicroStrategy stock rose about 5% as Bitcoin momentum boosted interest in its sizable BTC treasury, underscoring the ...
Tesla is betting big on AI by investing in xAI. This article explains what that move could mean for investors, how to...
Lumentum’s March 23 S&P 500 inclusion has sparked renewed buying and a broader market debate about how far the rally ...
AppLovin is set to report Q1 2026 after the close, with traders eyeing revenue momentum, margins and AI advertising s...
Payrolls rose by 115,000 in April, beating forecasts as the unemployment rate held at 4.3%. The report comes as oil-m...
Quantum computing stocks IonQ and D-Wave have drawn big attention after a steep rally. This guide breaks down what ha...
When a mid-cap medical device stock vaults over 5 percent in a single session, investors sit up and take notice. This...
Figma’s latest revenue surge has caught the eye of investors staring at a beaten-down stock. This article breaks down...
Value seekers are spotting a window: a well-known tech name trading at a discount as AI momentum roars. Here’s how to...
Ethereum faces renewed selling pressure after a failed attempt to reclaim key resistance. As the week unfolds, trader...
What looked like a cautious second quarter instead became a showcase of corporate resilience. This piece breaks down ...